Go Pro
→ A letter from Shannon Stansberry (From Porter & Company) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
$0.69
-0.7%		$0.79
$0.38
▼
$2.45
$109.47M2.291.96 million shs622,067 shs
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
$1.72
-1.1%		$1.83
$1.60
▼
$4.67
$116.87M1.04529,463 shs309,786 shs
Inspira Technologies OXY B.H.N. Ltd stock logo
QTEX
Inspira Technologies OXY B.H.N.
$0.90
+8.4%		$1.60
$0.28
▼
$3.85
$29.84M4.23.23 million shs1.91 million shs
Vivani Medical, Inc. stock logo
VANI
Vivani Medical
$1.28
-1.5%		$1.27
$0.92
▼
$1.92
$112.11M2.331.01 million shs33,535 shs
7 Energy Stocks to Buy and Hold Forever Cover
7 Energy Stocks to Buy and Hold Forever

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
-0.72%-11.38%-12.96%-2.04%-62.36%
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
-1.15%+0.58%-9.95%-18.10%-33.59%
Inspira Technologies OXY B.H.N. Ltd stock logo
QTEX
Inspira Technologies OXY B.H.N.
+8.42%+2.15%-40.40%+89,999,900.00%+89,999,900.00%
Vivani Medical, Inc. stock logo
VANI
Vivani Medical
-1.54%0.00%+4.07%-5.88%-10.49%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
$0.69
-0.7%		$0.79
$0.38
▼
$2.45
$109.47M2.291.96 million shs622,067 shs
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
$1.72
-1.1%		$1.83
$1.60
▼
$4.67
$116.87M1.04529,463 shs309,786 shs
Inspira Technologies OXY B.H.N. Ltd stock logo
QTEX
Inspira Technologies OXY B.H.N.
$0.90
+8.4%		$1.60
$0.28
▼
$3.85
$29.84M4.23.23 million shs1.91 million shs
Vivani Medical, Inc. stock logo
VANI
Vivani Medical
$1.28
-1.5%		$1.27
$0.92
▼
$1.92
$112.11M2.331.01 million shs33,535 shs
7 Energy Stocks to Buy and Hold Forever Cover
7 Energy Stocks to Buy and Hold Forever

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
-0.72%-11.38%-12.96%-2.04%-62.36%
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
-1.15%+0.58%-9.95%-18.10%-33.59%
Inspira Technologies OXY B.H.N. Ltd stock logo
QTEX
Inspira Technologies OXY B.H.N.
+8.42%+2.15%-40.40%+89,999,900.00%+89,999,900.00%
Vivani Medical, Inc. stock logo
VANI
Vivani Medical
-1.54%0.00%+4.07%-5.88%-10.49%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
2.50
Moderate Buy$5.12647.45% Upside
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
3.00
Buy$6.63285.17% Upside
Inspira Technologies OXY B.H.N. Ltd stock logo
QTEX
Inspira Technologies OXY B.H.N.
1.00
SellN/AN/A
Vivani Medical, Inc. stock logo
VANI
Vivani Medical
2.25
Hold$3.75192.97% Upside

Current Analyst Ratings Breakdown

Latest QTEX, GUTS, VANI, and MBOT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/22/2026
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
Zacks Research logo
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeHold ➝ Strong-Buy
7/14/2026
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
HC Wainwright logo
HC Wainwright
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy
7/8/2026
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
7/7/2026
Vivani Medical, Inc. stock logo
VANI
Vivani Medical
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (E+) ➝ Sell (D-)
7/6/2026
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (E+) ➝ Sell (D-)
7/1/2026
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
Craig Hallum logo
Craig Hallum
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageBuy$4.00
7/1/2026
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
Craig Hallum logo
Craig Hallum
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageBuy$4.00
6/23/2026
Vivani Medical, Inc. stock logo
VANI
Vivani Medical
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeSell (D-) ➝ Sell (E+)
6/23/2026
Vivani Medical, Inc. stock logo
VANI
Vivani Medical
Lake Street Capital logo
Lake Street Capital
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageBuy$4.00
6/23/2026
Vivani Medical, Inc. stock logo
VANI
Vivani Medical
Lake Street Capital logo
Lake Street Capital
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageBuy$4.00
6/9/2026
Vivani Medical, Inc. stock logo
VANI
Vivani Medical
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
(Data available from 8/1/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
$90K1,207.50N/AN/A$0.07 per share9.79
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
N/AN/AN/AN/A$1.15 per shareN/A
Inspira Technologies OXY B.H.N. Ltd stock logo
QTEX
Inspira Technologies OXY B.H.N.
$289K111.95N/AN/A$0.06 per share15.00
Vivani Medical, Inc. stock logo
VANI
Vivani Medical
N/AN/AN/AN/A$0.20 per shareN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
-$140.95M-$1.29N/AN/AN/AN/A-4,053.15%-96.41%8/11/2026 (Estimated)
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
-$13.14M-$0.26N/AN/AN/AN/A-21.84%-20.71%8/11/2026 (Estimated)
Inspira Technologies OXY B.H.N. Ltd stock logo
QTEX
Inspira Technologies OXY B.H.N.
-$13.22MN/AN/AN/AN/AN/AN/AN/AN/A
Vivani Medical, Inc. stock logo
VANI
Vivani Medical
-$26.61M-$0.40N/AN/AN/AN/A-264.04%-79.85%8/12/2026 (Estimated)

Latest QTEX, GUTS, VANI, and MBOT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/12/2026Q2 2026
Vivani Medical, Inc. stock logo
VANI
Vivani Medical
-$0.08N/AN/AN/AN/AN/A
8/11/2026Q2 2026
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
-$0.15N/AN/AN/AN/AN/A
8/11/2026Q2 2026
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
-$0.08N/AN/AN/A$0.33 millionN/A
5/13/2026Q1 2026
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
-$0.08-$0.05+$0.03-$0.05$0.30 million$0.11 million
5/13/2026Q1 2026
Vivani Medical, Inc. stock logo
VANI
Vivani Medical
-$0.08-$0.08N/A-$0.08N/AN/A
5/12/2026Q1 2026
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
-$0.17$0.06+$0.23$0.06N/AN/A
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
N/AN/AN/AN/AN/A
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
N/AN/AN/AN/AN/A
Inspira Technologies OXY B.H.N. Ltd stock logo
QTEX
Inspira Technologies OXY B.H.N.
N/AN/AN/AN/AN/A
Vivani Medical, Inc. stock logo
VANI
Vivani Medical
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
1.41
4.28
4.28
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
0.01
22.59
21.93
Inspira Technologies OXY B.H.N. Ltd stock logo
QTEX
Inspira Technologies OXY B.H.N.
0.08
1.56
1.30
Vivani Medical, Inc. stock logo
VANI
Vivani Medical
N/A
3.18
3.18

Institutional Ownership

CompanyInstitutional Ownership
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
N/A
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
16.30%
Inspira Technologies OXY B.H.N. Ltd stock logo
QTEX
Inspira Technologies OXY B.H.N.
12.72%
Vivani Medical, Inc. stock logo
VANI
Vivani Medical
6.78%

Insider Ownership

CompanyInsider Ownership
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
8.52%
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
4.74%
Inspira Technologies OXY B.H.N. Ltd stock logo
QTEX
Inspira Technologies OXY B.H.N.
29.40%
Vivani Medical, Inc. stock logo
VANI
Vivani Medical
53.30%
CompanyEmployeesShares OutstandingFree FloatOptionable
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
102158.65 million145.13 millionN/A
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
2067.17 million63.98 millionOptionable
Inspira Technologies OXY B.H.N. Ltd stock logo
QTEX
Inspira Technologies OXY B.H.N.
2035.95 million25.38 millionN/A
Vivani Medical, Inc. stock logo
VANI
Vivani Medical
2086.24 million40.27 millionOptionable

Recent News About These Companies

Vivani Medical Eyes August Human Trial for Semaglutide Implant After Novo Nordisk Deal
July 15, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/vivani-medical-eyes-august-human-trial-for-semaglutide-implant-after-novo-nordisk-deal-2026-07-15/
Vivani Medical to Present at the Emerging Growth Conference on July 15, 2026
July 14, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/14/3327241/0/en/vivani-medical-to-present-at-the-emerging-growth-conference-on-july-15-2026.html
Next Frontier In Weight Loss? New Implant Looks To Lock In GLP-1 Results
July 14, 2026  |  msn.comhttps://www.msn.com/en-in/health/other/next-frontier-in-weight-loss-new-implant-looks-to-lock-in-glp-1-results/ar-AA27Qwhm
The next GLP-1 bet? Implant draws Novo interest
July 13, 2026  |  beckershospitalreview.comB
Vivani Medical
July 13, 2026  |  fool.comhttps://www.fool.com/quote/nasdaq/vani/
Weight-loss implant could one day replace Ozempic injections
July 12, 2026  |  msn.comhttps://www.msn.com/en-us/health/weightloss/weight-loss-implant-could-one-day-replace-ozempic-injections/ar-AA27Krdd
Analysts Set Expectations for Vivani Medical Q1 Earnings
July 10, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/analysts-set-expectations-for-vivani-medical-q1-earnings-2026-07-10/
Novo Nordisk (CPSE:NOVO B) Could Be 13% Overvalued Following Its Vivani Deal
July 9, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/novo-nordisk-cpse-novo-b-161205528.html
Vivani Medical signs agreement with Novo Nordisk to evaluate NPM-139
July 9, 2026  |  pharmabiz.comP
Ozempic & Wegovy maker to evaluate long-acting GLP-1 implant that could last up to a year
July 9, 2026  |  msn.comhttps://www.msn.com/en-in/health/other/ozempic-wegovy-maker-to-evaluate-long-acting-glp-1-implant-that-could-last-up-to-a-year/ar-AA27wJgC
Novo Nordisk pens long-acting GLP-1 implant tech deal with Vivani Medical
July 7, 2026  |  fiercebiotech.comF
Novo Nordisk (CPSE:NOVO B) Teams Up With Vivani To Test A Semaglutide Implant
July 7, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/novo-nordisk-cpse-novo-b-191804898.html
Vivani Medical Enters into Agreement with Novo Nordisk to Evaluate NPM-139, a Miniature, Ultra Long-Acting Semaglutide Implant for Chronic Weight Management
July 7, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/07/3323068/0/en/vivani-medical-enters-into-agreement-with-novo-nordisk-to-evaluate-npm-139-a-miniature-ultra-long-acting-semaglutide-implant-for-chronic-weight-management.html
Vivani strikes reverse-merger agreement with ClearOne for BCI business
July 3, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/vivani-strikes-reverse-merger-agreement-114021364.html
ClearOne to Merge With Vivani Medical Subsidiary Cortigent
July 2, 2026  |  marketwatch.comhttps://www.marketwatch.com/story/clearone-to-merge-with-vivani-medical-subsidiary-cortigent-71872d96
Vivani to sell neurotech subsidiary Cortigent to ClearOne
July 2, 2026  |  massdevice.comhttps://www.massdevice.com/vivani-sell-neurotech-subsidiary-cortigent-clearone/
ClearOne Announces Entry into Merger Agreement with Cortigent, Inc., a Wholly-Owned Subsidiary of Vivani Medical
July 2, 2026  |  businesswire.comhttps://www.businesswire.com/news/home/20260702293602/en/clearone-announces-entry-into-merger-agreement-with-cortigent-inc.-a-wholly-owned-subsidiary-of-vivani-medical/
Vivani Announces Entry into Merger Agreement Between Wholly Owned Subsidiary Cortigent, Inc. and Nasdaq-listed ClearOne, Inc.
July 2, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/02/3321264/0/en/vivani-announces-entry-into-merger-agreement-between-wholly-owned-subsidiary-cortigent-inc-and-nasdaq-listed-clearone-inc.html
Vivani Medical Announces Appointment of August J. Moretti to Board of Directors and Retirement ...
June 26, 2026  |  caledonianrecord.comC
Vivani Medical Announces Appointment of August J. Moretti to Board of Directors and Retirement of Dr. Dean Baker
June 26, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/06/26/3318161/0/en/vivani-medical-announces-appointment-of-august-j-moretti-to-board-of-directors-and-retirement-of-dr-dean-baker.html
Vivani Medical Receives Bellberry Approval to Initiate Phase 1 SLIM-1 Trial of NPM-139 Semaglutide Implant
June 25, 2026  |  quiverquant.comQ

New MarketBeat Followers Over Time

Media Sentiment Over Time

Fractyl Health stock logo

Fractyl Health NASDAQ:GUTS

$0.68 -0.01 (-0.72%)
Closing price 07/31/2026 04:00 PM Eastern
Extended Trading
$0.70 +0.01 (+1.75%)
As of 07/31/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. The company develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans. It also develops Rejuva, a novel adeno-associated virus delivered pancreatic gene therapy platform that is designed to enable long-term remission of T2D and obesity by durably altering metabolic hormone function in the pancreatic islet cells of patients. Fractyl Health, Inc. was formerly known as Fractyl Laboratories Inc. and changed its name to Fractyl Health, Inc. on June 09, 2021. The company was incorporated in 2010 and is headquartered in Burlington, Massachusetts.

Microbot Medical stock logo

Microbot Medical NASDAQ:MBOT

$1.72 -0.02 (-1.15%)
Closing price 07/31/2026 04:00 PM Eastern
Extended Trading
$1.70 -0.01 (-0.87%)
As of 07/31/2026 07:40 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Braintree, Massachusetts.

Inspira Technologies OXY B.H.N. stock logo

Inspira Technologies OXY B.H.N. NASDAQ:QTEX

$0.90 +0.07 (+8.42%)
Closing price 07/31/2026 04:00 PM Eastern
Extended Trading
$0.88 -0.02 (-2.56%)
As of 07/31/2026 07:47 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation (MV) for the treatment of respiratory failure. Its lead product is the augmented respiration technology system (ART), a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels. The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N. Ltd. in July 2020. The company was incorporated in 2018 and is based in Ra'annana, Israel.

Vivani Medical stock logo

Vivani Medical NASDAQ:VANI

$1.28 -0.02 (-1.54%)
Closing price 07/31/2026 04:00 PM Eastern
Extended Trading
$1.30 +0.01 (+1.17%)
As of 07/31/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Vivani Medical, Inc., a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals. The company is headquartered in Emeryville, California.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas